ARTV

Artiva Biotherapeutics, Inc.

Contracts

Total Value

Stock Metrics

32.0%

Short % Float

5.1d to cover · High squeeze

84.0%

Inst % Float

10 holders · 2026-06-30

RA Capital Managem

Top Holder

20.1% of float

6.0M sh

Public Float

53/100

Dilution Score

High

14 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

53/100

HIGH

Inst: 84.05% · Top: RA Capital Management, L.P.

Biotech Analytics

Biotech / Pharma

26.53

Dilution Risk: HIGHSqueeze risk: HIGHBiotech Grade: F

Insider Buying0

Publications95

Dilution Risk53

Clinical Trials25

Short Interest90